background
relev
allerg
sensit
judg
titer
serum
ige
antibodi
risk
asthma
exacerb
caus
rhinoviru
unclear
object
sought
examin
preval
rhinoviru
infect
relat
atop
statu
children
treat
wheez
costa
rica
countri
increas
asthma
burden
method
children
enrol
n
year
old
includ
acut
wheez
stabl
asthma
nonasthmat
control
subject
pcr
method
includ
gene
sequenc
identifi
rhinoviru
strain
use
identifi
viral
pathogen
nasal
wash
result
examin
relat
wheez
ige
allergenspecif
ige
antibodi
fraction
exhal
nitric
oxid
level
result
sixtyfour
percent
wheez
children
compar
children
stabl
asthma
nonasthmat
control
subject
posit
test
result
rhinoviru
p
comparison
among
wheez
subject
rhinovirus
detect
group
c
strain
high
titer
ige
antibodi
dust
mite
allergen
especi
dermatophagoid
speci
common
correl
significantli
total
ige
fraction
exhal
nitric
oxid
level
greatest
risk
wheez
observ
among
children
titer
ige
antibodi
dust
mite
iuml
greater
test
posit
rhinoviru
odd
ratio
wheez
ci
p
conclus
high
titer
ige
antibodi
dust
mite
allergen
common
significantli
increas
risk
acut
wheez
provok
rhinoviru
among
asthmat
children
j
allergi
clin
immunol
countri
temper
climat
eg
north
america
europ
australia
viral
respiratori
tract
infect
associ
wheez
attack
pediatr
popul
especi
earli
childhood
year
age
rhinoviru
account
virusinduc
attack
lead
hospit
emerg
depart
ed
visit
major
children
atop
evid
date
also
indic
rhinoviru
infect
togeth
sensit
exposur
inhal
allergen
increas
risk
acut
symptom
suggest
risk
factor
might
act
synergist
provok
asthma
exacerb
whether
observ
gener
children
live
countri
tropic
climat
clear
studi
brazil
trinidad
preval
infect
rhinoviru
among
children
treat
asthma
less
half
report
countri
temper
climat
recogn
addit
studi
need
tropic
environ
gain
better
understand
role
viral
infect
caus
asthma
exacerb
worldwid
purpos
investig
examin
preval
viral
respiratori
tract
infect
among
children
treat
acut
wheez
costa
rica
evalu
result
relat
atop
statu
costa
rica
small
countri
squar
mile
central
america
divers
ecosystem
similar
countri
near
equat
costa
rica
season
dri
season
gener
decemb
april
raini
season
may
novemb
exposur
helminth
like
environment
allergen
stimul
product
ige
common
econom
depriv
region
hispan
america
howev
antihelminth
medic
given
annual
children
costa
rica
start
year
age
thu
activ
parasit
enter
infect
childhood
frequent
countri
eg
infect
ascari
lumbricoid
accord
school
survey
studi
use
intern
studi
asthma
allergi
childhood
questionnair
preval
asthma
among
schoolag
children
costa
rica
approxim
higher
north
america
sensit
allergen
especi
allergen
produc
hous
dust
mite
common
present
howev
littl
inform
relev
viral
infect
acut
attack
asthma
countri
addit
recent
evid
countri
temper
climat
suggest
group
c
strain
rhinoviru
might
strongli
relat
asthma
exacerb
compar
strain
inform
also
lack
studi
asthma
tropic
countri
thu
object
investig
relationship
respiratori
tract
virus
includ
differ
strain
rhinoviru
episod
asthma
requir
acut
treatment
addit
took
advantag
domin
dust
mite
sensit
costa
rica
investig
relationship
titer
ige
antibodi
exacerb
asthma
without
evid
recent
viral
infect
crosssect
casecontrol
investig
children
age
year
enrol
ed
hospit
nacion
de
main
tertiari
care
hospit
children
san
jo
e
costa
rica
major
children
seen
trauma
wheez
ill
vomit
diarrhea
abdomin
pain
fever
subject
includ
children
refer
acut
care
nebul
room
wheez
triag
physician
requir
least
nebul
bronchodil
albuterol
treatment
children
seen
ed
nonwheez
disord
n
enrol
control
subject
includ
children
hospit
treat
ed
use
medic
prescrib
physician
asthma
last
month
data
latter
group
defin
stabl
asthma
time
enrol
compar
data
obtain
activ
wheez
children
nonwheez
control
subject
post
hoc
analysi
children
chronic
lung
diseas
congenit
heart
diseas
immunodefici
oncolog
disord
enrol
subject
includ
children
wheez
enrol
februari
dri
season
children
costa
rica
begin
school
year
children
wheez
enrol
octob
raini
season
month
end
school
year
demograph
inform
subject
characterist
obtain
questionnair
administ
parent
questionnair
focus
child
histori
asthma
treatment
famili
histori
allerg
disord
environment
tobacco
smoke
et
exposur
home
inform
consent
obtain
parent
inform
assent
obtain
children
particip
studi
approv
ethic
committe
hospit
nacion
de
institut
review
board
univers
virginia
nasal
wash
obtain
viral
analys
describ
method
section
articl
onlin
repositori
wwwjacionlineorg
initi
evalu
rhinoviru
use
rtpcr
describ
previous
respiratori
viral
pathogen
evalu
use
realtim
pcr
assay
obtain
center
diseas
control
prevent
accord
publish
procedur
assay
includ
test
rhinoviru
well
test
influenza
includ
b
respiratori
syncyti
viru
rsv
human
metapneumoviru
parainfluenza
virus
coronavirus
speci
adenoviru
high
degre
concord
observ
rtpcr
realtim
pcr
method
detect
rhinoviru
percentag
absolut
agreement
ci
addit
strain
rhinoviru
enteroviru
identifi
mean
pcr
sequenc
region
compris
partial
capsid
protein
gene
measur
total
serum
ige
allergenspecif
ige
antibodi
fraction
exhal
nitric
oxid
level
blood
ml
obtain
mean
venipunctur
serum
sampl
analyz
total
ige
level
use
phadia
immunocap
assay
phadia
uppsala
sweden
sampl
also
analyz
allergenspecif
ige
antibodi
dust
mite
dermatophagoid
pteronyssinu
dermatophagoid
farina
blomia
tropicali
alternaria
speci
aspergillu
speci
cockroach
periplaneta
americana
blattella
germanica
bahia
grass
cat
dog
allergen
lumbricoid
sera
iuml
greater
ige
antibodi
allergen
test
consid
posit
allergen
sensit
fraction
exhal
nitric
oxid
feno
level
measur
portabl
feno
analyz
niox
mino
aerocrin
inc
new
provid
nj
questionnair
data
frequenc
posit
test
result
viral
pathogen
allergen
sensit
analyz
use
robust
exact
binomi
exact
multinomi
conting
tabl
method
binomi
conting
tabl
hypothes
evalu
use
exact
binomi
test
wherea
multinomi
conting
tabl
hypothes
evalu
use
pearson
exact
goodnessoffit
test
binomi
multinomi
conting
tabl
analys
null
hypothesi
reject
rule
set
p
valu
less
multivari
logist
regress
use
determin
whether
child
wheez
statu
associ
rhinoviru
infect
atop
statu
test
associ
base
type
iii
wald
x
statist
p
valu
less
use
identifi
signific
associ
total
serum
ige
level
titer
allergenspecif
ige
antibodi
feno
level
analyz
logarithm
scale
use
anova
sourc
variat
consid
anova
studi
group
season
data
collect
reject
rule
hypothesi
test
base
p
valu
less
ci
construct
ratio
geometr
mean
gm
base
student
test
distribut
statist
softwar
packag
sa
version
sa
institut
inc
cari
nc
use
conduct
statist
analys
among
control
children
enrol
present
ed
diagnosi
involv
breathless
stabl
asthma
judg
parent
report
treatment
regimen
percentag
wheez
children
stabl
asthma
requir
hospit
treatment
ed
use
medic
bronchodil
control
asthma
last
month
similar
tabl
minor
children
studi
expos
et
home
often
father
children
stabl
asthma
less
exposur
et
home
use
inhal
nasal
steroid
daili
often
children
enrol
wheez
tabl
detail
comparison
children
enrol
februari
octob
shown
tabl
articl
onlin
repositori
wwwjacionlineorg
percentag
children
posit
test
result
viru
significantli
greater
among
wheez
children
among
stabl
asthma
nonasthmat
control
subject
tabl
ii
percentag
similar
among
wheez
children
enrol
period
februari
octob
percentag
posit
test
respons
rhinoviru
also
significantli
greater
among
wheez
children
enrol
period
greater
among
wheez
children
enrol
februari
octob
p
fig
base
realtim
pcr
result
rhinoviru
account
viral
pathogen
detect
tabl
ii
rsv
enteroviru
predominantli
strain
pathogen
significantli
associ
wheez
respect
viral
pathogen
detect
wash
children
enrol
octob
fig
tabl
ii
gene
sequenc
reveal
nasal
wash
posit
test
result
rhinoviru
wheez
children
posit
group
c
strain
posit
group
strain
tabl
ii
percentag
rhinovirus
identifi
group
c
similar
among
wheez
children
enrol
februari
octob
respect
p
four
patient
stabl
asthma
posit
test
result
rhinoviru
also
posit
test
result
group
c
strain
comparison
rhinovirus
detect
wash
nonasthmat
control
subject
group
c
strain
respect
p
children
posit
test
result
group
b
strain
enrol
wheez
addit
inform
rhinoviru
strain
detect
shown
tabl
articl
onlin
repositori
wwwjacionlineorg
gm
total
ige
sera
wheez
children
iu
ml
ci
iuml
patient
stabl
asthma
iuml
ci
iuml
significantli
differ
p
valu
higher
total
ige
level
nonasthmat
control
subject
iuml
ci
iuml
p
ninetysix
percent
wheez
children
children
stabl
asthma
nonasthmat
control
subject
least
posit
test
result
ige
antibodi
allergen
test
p
patient
wheez
stabl
asthma
compar
control
subject
p
patient
wheez
compar
stabl
asthma
tabl
iii
frequent
ige
antibodi
respons
dust
mite
allergen
ie
pteronyssinu
farina
b
tropicali
strong
correl
observ
na
applic
symbol
mark
signific
differ
group
includ
follow
wheez
children
versu
nonasthmat
control
subject
kp
wheez
children
versu
children
stabl
asthma
p
p
p
children
stabl
asthma
versu
nonasthmat
control
subject
p
detail
shown
tabl
percentag
parent
report
child
asthma
wors
raini
dri
season
symptom
season
wheez
children
stabl
asthma
symptom
wors
raini
dri
season
p
compar
children
whose
symptom
season
p
children
wheez
stabl
asthma
matern
histori
asthma
significantli
higher
patern
histori
asthma
p
six
posit
test
result
enteroviru
posit
strain
previous
report
induc
attack
asthma
children
posit
test
result
ige
antibodi
pteronyssinu
farina
r
ci
p
among
wheez
stabl
asthma
group
preval
sensit
gm
ige
antibodi
titer
allergen
mite
speci
significantli
greater
compar
result
nonasthmat
control
subject
p
tabl
iii
addit
adjust
sensit
allergen
dust
mite
allergen
sensit
remain
significantli
associ
asthma
adjust
odd
ratio
ci
ige
b
tropicali
ci
ige
pteronyssinu
sensit
cockroach
speci
b
germanica
p
americana
helminth
lumbricoid
also
greater
among
wheez
children
stabl
asthma
compar
seen
nonasthmat
control
subject
tabl
iii
howev
preval
sensit
titer
ige
antibodi
gm
allergen
much
lower
valu
dust
mite
speci
addit
strong
correl
observ
total
serum
ige
level
titer
ige
antibodi
farina
pteronyssinu
b
tropicali
among
asthmat
subject
wheez
stabl
asthmat
children
combin
r
respect
p
data
allergen
ige
valu
februari
octob
shown
tabl
articl
onlin
repositori
wwwjacionlineorg
adjust
viral
pathogen
specif
ige
antibodi
main
pathogen
factor
remain
significantli
associ
wheez
among
children
enrol
posit
test
rhinoviru
adjust
odd
ratio
ci
p
odd
wheez
howev
strongli
influenc
titer
ige
antibodi
dust
mite
allergen
tabl
iv
moreov
probabl
enrol
acut
wheez
base
logist
regress
analys
significantli
associ
increas
titer
ige
antibodi
pteronyssinu
fig
risk
substanti
higher
among
posit
test
result
rhinoviru
fig
b
relationship
ige
antibodi
titer
group
c
rhinoviru
strain
group
rhinoviru
tabl
iv
addit
despit
smaller
number
virus
associ
wheez
rsv
enteroviru
show
trend
see
tabl
articl
onlin
repositori
wwwjacionlineorg
feno
level
gm
significantli
higher
among
wheez
children
ppb
ci
ppb
stabl
asthma
ppb
ci
ppb
compar
level
among
nonasthmat
control
subject
ppb
ci
ppb
p
comparison
p
wheez
compar
children
stabl
asthma
feno
level
also
higher
among
posit
test
result
compar
seen
subject
neg
test
result
rhinoviru
compar
ppb
p
similar
among
posit
test
result
group
c
group
strain
vs
ppb
respect
p
posit
correl
observ
feno
level
titer
ige
antibodi
mite
sera
children
within
enrol
group
fig
contrast
feno
level
associ
sensit
cockroach
speci
ascari
speci
infect
rhinoviru
often
group
c
strain
strongli
associ
activ
wheez
among
children
age
year
live
costa
rica
wheez
children
studi
atop
larg
major
sensit
dust
mite
allergen
moreov
titer
ige
antibodi
dust
mite
among
children
enrol
wheez
well
stabl
asthma
significantli
greater
allergen
test
taken
togeth
first
studi
demonstr
children
high
titer
ige
antibodi
studi
predominantli
dust
mite
allergen
greatest
risk
attack
wheez
provok
rhinoviru
addit
result
demonstr
pathogen
effect
individu
strain
rhinoviru
respiratori
tract
virus
might
difficult
determin
without
understand
atop
characterist
host
rational
enrol
subject
ed
children
could
evalu
without
knowledg
atop
statu
whether
recent
infect
viral
pathogen
popul
subject
enrol
wheez
stabl
asthma
similar
allergenspecif
ige
respons
total
ige
feno
level
significantli
increas
compar
nonasthmat
control
subject
adjust
atop
characterist
exposur
et
home
daili
use
inhal
nasal
steroid
main
pathogen
factor
differenti
children
requir
treatment
wheez
stabl
asthma
posit
test
rhinoviru
previou
studi
brazil
trinidad
rhinoviru
infect
associ
attack
asthma
strongli
report
studi
countri
temper
climat
differ
lifestyl
eg
qualiti
drink
water
rate
helminth
infect
amount
time
spent
indoor
home
school
might
explain
differ
rate
infect
howev
costa
rica
region
brazil
around
paulo
develop
western
lifestyl
strong
associ
atopi
asthma
observ
countri
strain
rhinoviru
within
group
b
c
also
evalu
posit
test
rhinoviru
studi
major
wheez
children
infect
group
c
strain
ie
posit
group
c
posit
group
strain
significantli
associ
wheez
tabl
ii
studi
children
treat
exacerb
asthma
also
report
higher
frequenc
infect
group
c
strain
thu
far
studi
shown
signific
associ
asthma
group
b
strain
inform
relationship
rate
infect
strain
b
c
gener
popul
unclear
data
nonasthmat
control
subject
present
investig
well
younger
children
evalu
respiratori
tract
infect
studi
suggest
frequenc
infect
group
c
strain
might
similar
suggest
airway
patient
asthma
might
suscept
infect
group
c
strain
present
receptor
use
group
c
virus
infect
epitheli
cell
known
cellsurfac
receptor
use
group
strain
adhes
molecul
intercellular
adhes
molecul
previou
studi
includ
indic
express
solubl
membran
reduc
asthmat
airway
might
give
group
c
virus
select
advantag
infect
asthmat
respiratori
tract
epithelium
patient
popul
feno
specif
ige
level
similar
among
children
infect
group
c
group
strain
recent
signific
allergi
respons
rhinoviru
also
suggest
signific
decreas
asthma
exacerb
among
children
treat
na
applic
nd
determin
symbol
mark
signific
differ
group
includ
follow
children
wheez
versu
nonasthmat
control
subject
p
p
children
wheez
versu
stabl
asthma
p
p
children
stabl
asthma
versu
nonasthmat
control
subject
p
p
p
children
ige
antibodi
level
iuml
greater
allergen
antibodi
titer
shown
gm
gm
follow
ci
parenthes
dust
mite
speci
gm
allergen
includ
children
whose
allergenspecif
ige
level
iuml
greater
omalizumab
subset
infect
rv
benefici
effect
inhal
corticosteroid
also
reduc
h
inflamm
prevent
asthma
exacerb
childhood
also
support
observ
high
rate
sensit
dust
mite
among
children
asthma
costa
rica
describ
persist
humid
favor
mite
growth
throughout
year
although
measur
allergen
exposur
home
children
enrol
done
previou
investig
costa
rica
suggest
exposur
level
base
measur
guanin
estim
mite
allergen
concentr
dust
sampl
increas
throughout
year
might
higher
raini
season
persist
humid
support
mite
growth
also
present
new
zealand
unit
kingdom
high
titer
ige
antibodi
dust
mite
risk
asthma
also
observ
present
studi
high
titer
ige
antibodi
dust
mite
strongli
associ
asthma
significantli
increas
risk
acut
wheez
allergen
test
strike
signific
increas
probabl
wheez
recent
rhinoviru
infect
among
children
titer
ige
antibodi
pteronyssinu
iuml
greater
environment
antigen
capabl
stimul
ige
antibodi
might
exist
evalu
howev
judg
preval
titer
ige
antibodi
none
allergen
includ
studi
compar
result
observ
dust
mite
observ
gener
feno
asthmat
airway
correl
sensit
exposur
inhal
allergen
describ
previous
level
feno
among
asthmat
children
current
wheez
stabl
asthma
present
studi
significantli
higher
among
nonasthmat
control
subject
result
consist
result
experiment
challeng
demonstr
level
feno
significantli
increas
viru
inocul
among
asthmat
patient
high
level
total
ige
togeth
result
suggest
preexist
allerg
inflamm
main
risk
factor
asthmat
respons
rhinoviru
present
studi
posit
correl
titer
ige
pteronyssinu
farina
b
tropicali
feno
level
provid
evid
relev
dust
mite
allergen
pathogenesi
airway
inflamm
conclus
investig
highlight
signific
risk
asthma
attack
caus
rhinoviru
among
children
high
titer
ige
antibodi
often
associ
sensit
dust
mite
allergen
costa
rica
thu
far
antivir
treatment
includ
vaccin
treat
infect
rhinoviru
difficult
develop
antigen
divers
among
rhinoviru
strain
predisposit
asthmat
patient
becom
infect
group
c
strain
might
offer
target
approach
develop
antivir
treatment
howev
approach
would
effect
wheez
children
posit
test
result
rhinoviru
studi
might
effect
prevent
attack
asthma
caus
group
strain
altern
treatment
focus
decreas
allerg
airway
inflamm
could
provid
broader
approach
prevent
andor
decreas
sever
asthma
exacerb
caus
rhinoviru
thu
result
studi
provid
strong
evid
character
atop
statu
asthmat
children
greater
detail
includ
titer
allergenspecif
ige
antibodi
need
enhanc
investig
focus
mechan
rhinovirusinduc
attack
asthma
identifi
children
like
benefit
allergenspecif
therapi
thank
lyn
melton
time
help
prepar
manuscript
nasal
wash
obtain
viral
analys
child
breath
hold
sit
posit
use
mucos
atom
devic
wolf
tori
medic
inc
salt
lake
citi
utah
ml
pb
instil
nostril
nostril
wash
separ
wash
fluid
secret
aspir
immedi
use
bbg
nasal
aspir
codan
us
corp
santa
ana
calif
steril
mucu
trap
attach
wall
suction
one
millilit
pb
contain
gelatin
stabil
protein
wash
fluid
aspir
suction
devic
rins
residu
secret
trap
combin
wash
nostril
result
volum
ml
wash
fluid
nasal
secret
plastic
transfer
pipett
use
mix
secret
wash
fluid
aliquot
frozen
subsequ
analys
na
applic
symbol
mark
signific
differ
group
within
enrol
period
includ
follow
wheez
children
versu
nonasthmat
control
subject
p
p
wheez
children
versu
children
stabl
asthma
kp
p
children
stabl
asthma
versu
nonasthmat
control
subject
p
p
p
signific
differ
februari
octob
enrol
group
indic
follow
kkp
percentag
children
requir
treatment
ed
hospit
asthma
last
month
percentag
children
use
medic
bronchodil
control
asthma
timefram
indic
percentag
children
use
inhal
corticosteroid
nasal
steroid
montelukast
daili
percentag
children
miss
day
school
asthma
previou
year
children
dog
cat
exposur
home
parent
report
child
asthma
wors
raini
dri
season
asthma
symptom
season
wheez
children
stabl
asthma
enrol
februari
octob
experienc
asthma
symptom
raini
compar
dri
season
p
kkkpercentag
children
expos
least
person
home
smoke
cigarett
day
percentag
children
whose
mother
father
smoke
cigarett
day
titer
specif
total
serum
ige
antibodi
intern
unit
per
millilit
specif
ige
antibodi
titer
boldfac
consid
posit
ital
consid
high
titer
iuml
one
control
subject
serum
ige
data
posit
result
enteroviru
use
realtim
pcr
nasal
secret
subject
current
wheez
coinfect
enteroviru
rsv
subject
current
wheez
coinfect
rsv
human
rhinoviru
group
c
